NCT05417152View on ClinicalTrials.gov

Single In-Clinic Encounter With the Notal Vision Home OCT by DME Patients

CompletedOBSERVATIONAL

Enrollment

18

Participants

Timeline

Start Date

June 29, 2022

Primary Completion Date

November 30, 2022

Study Completion Date

March 30, 2023

Conditions

Diabetic Retinopathy

Trial Locations (1)

Unknown

Assuta Hashalom, Tel Aviv

Sponsors

Lead Sponsor

Notal Vision Inc.

All Listed Sponsors

lead

Notal Vision Inc.

INDUSTRY

NCT05417152 - Single In-Clinic Encounter With the Notal Vision Home OCT by DME Patients | Biotech Hunter | Biotech Hunter